Wright Medical Technology, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Planned merger with Cremascoli Ortho Group will expand the orthopedic surgical device maker's European presence and add complementary product lines, Wright announces Dec. 17. The transaction will be funded by Arlington, Tennessee-based Wright's principal shareholders - Warburg Pincus Equity Partners and Vertical Group - and is expected to close by year-end. Cremascoli Ortho has direct distribution in Italy, France, Great Britain, Belgium, Spain and Germany, as well as manufacturing facilities in France and R&D facilities in Italy
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.